Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Precision Nanomedicine is Scopus-indexed (Q3, CiteScore 1.9), DOAJ. Published by Andover House, Inc..
Checked against the index lists dated .
ISSN 2639-9431Verify ISSN ↗
Publisher: Andover House, Inc.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 254 / 466 | 45th | Q3 |
| Pharmaceutical Science | 117 / 191 | 39th | Q3 |
| Biochemistry (medical) | 52 / 78 | 33rd | Q3 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present, best quartile Q3, CiteScore 1.9.
Precision Nanomedicine is Q3 in Medicine (miscellaneous) (rank 254 of 466), Q3 in Pharmaceutical Science (rank 117 of 191) and Q3 in Biochemistry (medical) (rank 52 of 78), by CiteScore 2025.
Precision Nanomedicine is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 1.9, quartile Q3, 45th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.341, quartile Q3, with an H-index of 9.
Precision Nanomedicine is published by Andover House, Inc. Its ISSN is 2639-9431.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Precision Nanomedicine has an h-index of 14 and a 2-year mean of 1.37 citations per paper (OpenAlex). Its Scopus CiteScore is 1.9, quartile Q3. On 2-year citations it ranks #221 of 451 Scopus journals in Medicine (miscellaneous).
Precision Nanomedicine published 27 papers in 2025; its busiest recent year was 2018 with 31. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 77 research articles (2021–2026), authors are most often from United States (25.8%), India (17.4%) and Israel (5.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.